Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized，Cross-over Study

NCT02930616 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02930616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02930616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized，Cross-over Study
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2016
Completion date
June 30, 2017
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biopsy, confocal laser endomicroscopy, gastric intestinal metaplasia, operative link on gastric intestinal metaplasia